| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |